Medicare Expands Access for Weight Loss Drugs to Some Beneficiaries

Why it matters locally: The expanded Medicare coverage for GLP-1 weight loss medications is expected to have a significant impact on the health and healthcare landscape for Texas's large Medicare beneficiary population, potentially improving health outcomes and lowering long-term healthcare costs across the state.

The utilization of GLP-1 medications for weight loss has shown an increase among American adults. A new Gallup poll indicates that 11% of adults currently use one of these drugs. This represents a significant rise from two years prior, when 3% of adults reported using them. Medicare has now made it possible for some patients to obtain these medications. William Brangham discussed these developments with Juliette Cubanski.